GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q2 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $189.7 million versus the consensus estimate of $186.71 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.